Drugs / MMP with 5-FU
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02904564 | Aug 2016 → Jan 2020 | photosensitivity disease | Clinica Dermatologica Arbache ltda | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MMP with 5-FU | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02904564 ↗ |
| Known as | 5FU | “Assess the efficacy and safety of 5-fluorouracil (5FU) compared with saline, delivered using a tattoo machine, to repigment IGH lesions.” PMID 37011024 ↗ Apr 2023 |
| Route | Other | “5-fluorouracil (5FU) compared with saline, delivered using a tattoo machine” PMID 37011024 ↗ Apr 2023 |